Joint procurement of IOL-type medical consumables in Beijing, Tianjin and Hebei 9 provinces
At the end of April 2020, there was a joint procurement of IOL-type medical consumables in Beijing, Tianjin and Hebei 9 provinces.
22 May 2020 announced the joint procurement of the selected results notice shows that a total of 19 companies 44 products were selected, the average reduction of IOL is 53.72%, the highest reduction of 84.21%.
These involved Johnson & Johnson Visioncon, Nippon Nidec Corporation, Arion Technology Corporation, and Human Optics AG, among others.
As of October 2020, a total of 22 provinces nationwide have completed five rounds of IOL band purchasing, with price reductions ranging from 18% to 85%.
At present, several large inter-provincial alliances have been formed: the Beijing-Tianjin-Hebei "3+N" alliance, the Guangdong and other 16 provinces alliance, eight provinces and two regions, and the Sanming procurement alliance...
According to the collection trend, the coalition with volume procurement will continue to expand, the price will gradually achieve national linkage.

For the next set of procurement direction, the National Medical Security Bureau, deputy director Chen Jinfu said, will be normalized and institutionalized the amount of drugs and high-value medical supplies with procurement.
On the one hand, consolidate the new normal and promote the speed and expansion of collective procurement.
High-value medical consumables focus on orthopedic consumables, drug balloons, dental implants and other varieties, and strive to achieve an average of more than 350 drug varieties covered in each province and more than five varieties of high-value medical consumables through national organizations and provincial alliance procurement by the end of 2022, making it a new normal for pooling.
With regard to the collection of orthopedic consumables, drug balloons, dental implants and other consumable varieties, Chen Jinfu made it clear that this year, further extension to the spine consumables, so that orthopedic consumables basically reach the main coverage.
A mapping study of spinal consumables and standardization of information, including rules, is underway.
2026-07-26
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Egyptian Pharmaceutical Market Research
-
CPHI China 2023 | At the Heart of Pharma
-
A Guide Into What the Pharmaceutical Use of Hexamine Is
-
In line with the 8201, Hengrui Pharmaceutical plans the HER2 ADC in this way
-
$50 billion in products were 'returned' to rationalize those blockbuster BD deals
-
Tronsound long-acting IL-36R antibody obtained FDA clinical IND
-
Dapagliflozin is approved in the EU for the treatment of symptomatic chronic heart failure
-
The FDA accepted Zuranolone's NDA application and granted it priority review rights for the treatment of MDD and PDD
-
Asia Hong Pharma announced that it has co-developed an innovative tumor therapy based on AI+RNA technology route with ReviR
-
Ribo Biologics announced that the world's first FIH application for a siRNA drug targeting FXI has been successfully approved by HREC in Australia
Recommend Reading
-
Saint-Gobain Expands Its Construction Chemicals Operations in Indonesia
-
Indorama Corporation Acquires 100% Stake in Anyang Zhongying Fertilizer
-
“Anti-Overcapacity” Backfires: China’s Chemical Industry Trapped in a Hell of Its Own Making—and Global Pushback
-
The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
-
EU Greenlights Four GM Crops—But Only at the Border
-
Weak Demand Leads to Narrow Fluctuations in the Melamine Market in China
-
Ethanol Market Conditions Show Signs of Recovery
-
Soda Ash Market Remains Stable Amidst Caution
-
This week, China's acetone market continues to weaken
-
Negative Factors Suppress Adipic Acid Prices in China